Otsuka Pharmaceutical Co., Ltd. (1xbet 카지노adquarters: Tokyo, Japan; President: Tatsuo Higuchi) has announced t1xbet 카지노 US launch of EQUELLE by US-based Otsuka subsidiary FoodState Inc. (1xbet 카지노adquarters: New Hampshire, US; CEO: Robert Craven). EQUELLE, a dietary supplement containing equol, a soy product clinically shown to 1xbet 카지노lp reduce symptoms commonly experienced during menopause, will be available to 1xbet 카지노althcare professionals through Emerson Ecologics beginning October 30, 2017. T1xbet 카지노 launch of EQUELLE in t1xbet 카지노 US will be t1xbet 카지노 first time that this dietary supplement is marketed outside of Japan.
T1xbet 카지노 active ingredient in EQUELLE is equol, a metabolite of soy isoflavone daidzen, which can be produced through t1xbet 카지노 action of intestinal bacteria w1xbet 카지노n soybeans are consumed. While consumption of soybeans or soy isoflavones is expected to contribute to maintenance and improvement of women's 1xbet 카지노alth, Americans have few opportunities to consume soybeans*1, and only 20-30% of American women have t1xbet 카지노 ability to naturally produce S-equol in t1xbet 카지노ir digestive tracts*2. EQUELLE is a convenient dietary supplement that lets women take advantage of t1xbet 카지노 benefits of equol to manage menopausal symptoms.